In the last few years, research on the use of biochemical markers of bone turnover has
greatly improved. Among the several available bone turnover markers, monitoring serum C …

• C-terminal cross-linked telopeptide (CTX) are part of bone turnover biomarkers.• Analytical
performances of a new CTX automated were evaluated.• Our results showed a good …

Bone diseases such as osteoporosis or bone metastases are a continuously growing
problem in the ageing populations across the world. In recent years, great efforts have been …

Background: Biochemical markers of bone turnover can provide prognostic information
about the risk of osteoporotic fracture and are useful tools for monitoring efficacy of …

Background Biochemical bone turnover markers are useful tools to assess bone
remodeling. C-terminal telopeptide of type I collagen (ß-CTX) has been recommended as a …

Background: Urinary C-terminal telopeptide of type I collagen (u-CTx) has been reported to
be a sensitive biochemical marker of bone turnover. There have been two assays for urinary …

Introduction Plasma C-terminal telopeptide of type I collagen (CTX) is the nominated
reference bone resorption marker. We set out to test the agreement of patients' results …

Point-of-Care (PoC) measurement is defined as near-patient testing that is useful in
prognostic monitoring of various diseases by measuring specific biomarkers. The major …

Serum CTX assays measure a fragment of the C-terminal telopeptide of type 1 collagen
released during resorption of mature bone. Assay reagents are available in manual and …

Osteoporosis is a disease where increased bone weakness increases the risk of a broken
bone. Until a broken bone occurs, there are typically no symptoms. Osteoporosis affects …